Case Reports

Section Edited by Alfred Zippelius, MD

Multiomics analysis reveals a distinct response mechanism in multiple primary lung adenocarcinoma after neoadjuvant immunotherapy

Chao Zhang, Kai Yin, Si-Yang Liu, Li-Xu Yan, Jian Su, Yi-Long Wu, Xu-Chao Zhang, Wen-Zhao Zhong, Xue-Ning Yang

10.1136/jitc-2020-002312

April 5, 2021

αPD-1-mesoCAR-T cells partially inhibit the growth of advanced/refractory ovarian cancer in a patient along with daily apatinib

Juemin Fang, Na Ding, Xinling Guo, Yan Sun, Zhiwei Zhang, Bailu Xie, Zhong Li, Hui Wang, Wei Mao, Zhicai Lin, Fei Qin, Min Yuan, Wenqi Chu, Huanlong Qin, Qijun Qian, Qing Xu

10.1136/jitc-2020-001162

February 15, 2021

Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer

Romain Cohen, Vincent Jonchère, Christelle De La Fouchardière, Toky Ratovomanana, Quentin Letourneur, Mira Ayadi, Lucile Armenoult, Adrien Buisson, Matthieu Sarabi, Anna Pellat, Raphael Colle, Francois Paye, Pierre Meeus, Magali Svrcek, Alex Duval, Thierry Andre

10.1136/jitc-2020-001903

February 12, 2021

COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report

Angelo Dipasquale, Pasquale Persico, Elena Lorenzi, Daoud Rahal, Armando Santoro, Matteo Simonelli

10.1136/jitc-2020-001870

February 11, 2021

Short-term response to immune-chemotherapy and immune features of a ceritinib-resistant patient with ROS1-rearranged lung adenocarcinoma

Dongsheng Yue, Juanjuan Qian, Zhipeng Chen, Bin Zhang, Peng Chen, Lei Zhang, Jingjing Li, Henghui Zhang, Changli Wang

10.1136/jitc-2020-001967

February 8, 2021

Tisagenlecleucel infusion in patients with relapsed/refractory ALL and concurrent serious infection

Erin M Hall, Dwight E Yin, Rakesh K Goyal, Atif A Ahmed, Grace S Mitchell, Shawn D St. Peter, Terrie G Flatt, Ibrahim A Ahmed, Weijie Li, Richard J Hendrickson, Keith J August, G Doug Myers

10.1136/jitc-2020-001225

January 20, 2021

Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report

Carolin Blumendeller, Julius Boehme, Maximilian Frick, Martin Schulze, Antje Rinckleb, Christina Kyzirakos, Simone Kayser, Maria Kopp, Sabine Kelkenberg, Natalia Pieper, Oliver Bartsch, Dirk Hadaschick, Florian Battke, Arnulf Stenzl, Saskia Biskup

10.1136/jitc-2020-001406

January 11, 2021

Immune-mediated ototoxicity associated with immune checkpoint inhibitors in patients with melanoma

Samuel Rosner, Yuri Agrawal, Daniel Q Sun, Nafi Aygun, Megan D Schollenberger, Evan Lipson, Jarushka Naidoo

10.1136/jitc-2020-001675

December 16, 2020

Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia

George Mo, Hao-Wei Wang, Aimee C Talleur, Shilpa A Shahani, Bonnie Yates, Haneen Shalabi, Michael G Douvas, Katherine R Calvo, Jack F Shern, Sridhar Chaganti, Katharine Patrick, Young Song, Terry J Fry, Xiaolin Wu, Brandon M Triplett, Javed Khan, Rebecca A Gardner, Nirali N Shah

10.1136/jitc-2020-001563

November 27, 2020

Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy

Won Jin Ho, Gaurav Sharma, Qingfeng Zhu, Genevieve Stein-O'Brien, Jennifer Durham, Robert Anders, Aleksandra Popovic, Guanglan Mo, Ihab Kamel, Matthew Weiss, Elizabeth Jaffee, Elana J Fertig, Mark Yarchoan

10.1136/jitc-2020-000932

November 20, 2020